Show results for
Refine by
Cell Therapeutic Equipment Supplied In Canada
7 equipment items found
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Use the Thermo Scientific™ Nunc™ Automatic Cell Factory™ Manipulator System (ACFM), which features electronic and pneumatic controls, to automate the filling and emptying of a medium or cell suspension into 4 x 3 Nunc Cell Factory 10 systems or 4 x 1 Nunc Cell Factory 40. Specifically designed to lend innovation ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Use the Thermo Scientific™ Nunc™ Automatic Cell Factory™ Manipulator System (ACFM), which features electronic and pneumatic controls, to automate the filling and emptying of a medium or cell suspension into 4 x 3 Nunc Cell Factory 10 systems or 4 x 1 Nunc Cell Factory 40. Specifically designed to lend innovation ...
Manufactured by:Acuitas Therapeutics based inVancouver, BRITISH COLUMBIA (CANADA)
Proteins are the “workhorses” within cells responsible for metabolic processes, transport processes and structural elements. They are coded by genes on DNA and this code is transcribed into a message (messenger RNA or mRNA) within the cell nucleus. This mRNA then leaves the nucleus and is translated into the protein on ribosomes (Figure 1). ...
by:Aspect Biosystems Ltd. based inVancouver, BRITISH COLUMBIA (CANADA)
Accurately recreate complex and functional physiological structures for medical research, therapeutic discovery and regenerative medicine using the Aspect ...
Manufactured by:Hemostemix Inc. based inCalgary, ALBERTA (CANADA)
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The synergetic cell population, which can be collected from a simple blood draw, consists of progenitor and other supporting cells that are being developed for ...
Manufactured by:BlueRock Therapeutics based inCambridge, MASSACHUSETTS (USA)
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. ...